Clinical Trials on Seborrheic Blepharitis
Total 126 results
-
Istanbul University - Cerrahpasa (IUC)Koç UniversityCompleted
-
Istanbul University - Cerrahpasa (IUC)Koç UniversityCompleted
-
PeplinCompletedSeborrheic KeratosisAustralia
-
Astion Pharma A/SCompletedSeborrheic Dermatitis
-
Moberg Pharma ABCompletedSeborrhoeic Eczema of the ScalpSweden
-
Moberg Pharma ABCompletedSeborrhoeic Dermatitis of the ScalpSweden
-
Federal University of São PauloUnknownQuality of Life | Seborrheic Dermatitis | SeborrheaBrazil
-
Mimetica Pty LimitedCompletedSeborrhea | Oily SkinUnited States
-
Laboratoires TheaCompleted
-
NTC srlCompletedBilateral Blepharitis (Disorder)Italy
-
Tarsus Pharmaceuticals, Inc.RecruitingDemodex BlepharitisUnited States
-
Shaare Zedek Medical CenterRecruiting
-
University of California, Los AngelesTerminatedAnterior BlepharitisUnited States
-
Sun Pharmaceutical Industries LimitedCompletedActive, Symptomatic BlepharitisUnited States
-
Aclaris Therapeutics, Inc.CompletedSeborrheic Keratosis (SK)United States
-
Universidad Nacional de ColombiaCompletedChronic BlepharitisColombia
-
Tissue Tech Inc.National Eye Institute (NEI)Completed
-
Tehran University of Medical SciencesCompletedPosterior BlepharitisIran, Islamic Republic of
-
AxeroVision, Inc.CompletedMeibomian Gland Dysfunction | Posterior BlepharitisUnited States
-
Reza Dana, MDCompletedPosterior Blepharitis
-
University of the Incarnate WordCompletedDry Eye | Meibomian Gland Dysfunction | Posterior BlepharitisUnited States
-
Galderma R&DCompletedScalp Seborrheic DermatitisBelgium, France, Germany, Korea, Republic of, Mexico
-
Promius Pharma, LLCCompleted
-
University of California, DavisCompleted
-
University Hospital, RouenCompletedSevere Seborrheic DermatitisFrance
-
LEO PharmaBayerCompletedSeborrheic Dermatitis on the FaceGermany
-
DermBiont, Inc.Zepeda DermatologiaActive, not recruitingSeborrheic KeratosisEl Salvador
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Milton S. Hershey Medical CenterCompletedSeborrheic KeratosisUnited States
-
DermBiont, Inc.Active, not recruitingA Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic KeratosisSeborrheic KeratosisUnited States
-
Indonesia UniversityCompletedSeborrheic Keratosis | AcrochordonIndonesia
-
Dermatology Specialists ResearchNovartisCompletedSeborrheic DermatitisUnited States
-
University of Alabama at BirminghamCompletedSeborrheic DermatitisUnited States
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Medicis Global Service CorporationCompletedSeborrheic DermatitisUnited States
-
Lexington International, LLCCompleted
-
Pulse Biosciences, Inc.CompletedSeborrheic Keratosis | Lesion SkinUnited States
-
Sun Pharmaceutical Industries LimitedCompleted
-
University of Notre DameUnknown
-
University of CologneOptima Pharmazeutische GmbHCompleted
-
Aclaris Therapeutics, Inc.Completed
-
Aclaris Therapeutics, Inc.Completed
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
St. Louis UniversityCompletedSeborrheic DermatitisUnited States
-
Icahn School of Medicine at Mount SinaiIncyte CorporationCompleted
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States, Canada
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States, Canada